Related references
Note: Only part of the references are listed.Vaccine-Induced Control of Viral Shedding following Rhesus Cytomegalovirus Challenge in Rhesus Macaques
Kristina Abel et al.
JOURNAL OF VIROLOGY (2011)
Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection
Christof Geldmacher et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit
Antonio Valentin et al.
VACCINE (2010)
The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
Rajesh T. Gandhi et al.
PLOS MEDICINE (2010)
Detection of polyfunctional Mycobacterium tuberculosis-specific T cells and association with viral load in HIV-1-infected persons
Cheryl L. Day et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
A heterologous DNA prime/protein boost immunization strategy for rhesus cytomegalovirus
Kristina Abel et al.
VACCINE (2008)
Dynamics of simian immunodeficiency virus Populations in blood and cerebrospinal fluid over the full course of infection
Patrick R. Harrington et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Immunogenicity and protective efficacy of DNA vaccines expressing rhesus cytomegalovirus glycoprotein B, phosphoprotein 65-2, and viral interleukin-10 in rhesus macaques
Yujuan Yue et al.
JOURNAL OF VIROLOGY (2007)
Long-lasting decrease in viremia in macaques chronically infected with simian immunodeficiency virus SIVmac251 after therapeutic DNA immunization
Agneta S. von Gegerfelt et al.
JOURNAL OF VIROLOGY (2007)
Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation
Joseph P. Casazza et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Therapeutic immunization for HIV
Lindvi Gudmundsdotter et al.
SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2006)
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
Michael R. Betts et al.
BLOOD (2006)
A dose sparing effect by plasmid encoded IL-12 adjuvant on a SlVgag-plasmid DNA vaccine in rhesus macaques
Eva B. Schadeck et al.
VACCINE (2006)
DNA immunization in combination with effective antiretroviral drug therapy controls viral rebound and prevents simian AIDS after treatment is discontinued
DH Fuller et al.
VIROLOGY (2006)
HIV-1-specific CD4(+) T cell responses in chronically HIV-1 infected blippers on antiretroviral therapy in relation to viral replication following treatment interruption
E Papasavvas et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2006)
SIV DNA vaccine co-administered with IL-12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques
JD Boyer et al.
JOURNAL OF MEDICAL PRIMATOLOGY (2005)
DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replication
JD Boyer et al.
VIROLOGY (2005)
Continued production of drug-sensitive human immunodeficiency virus type 1 in children on combination antiretroviral therapy who have undetectable viral loads
D Persaud et al.
JOURNAL OF VIROLOGY (2004)
Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection
RS Veazey et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
A Gag-Pol/Env-Rev SIV239 DNA vaccine improves CD4 counts, and reduce viral loads after pathogenic intrarectal SIVmac251 challenge in Rhesus Macaques
K Muthumani et al.
VACCINE (2003)
Therapeutic dendritic-cell vaccine for simian AIDS
W Lu et al.
NATURE MEDICINE (2003)
Prevalence and clinical correlates of HIV viremia ('blips') in patients with previous suppression below the limits of quantification
PA Sklar et al.
AIDS (2002)
HIV preferentially infects HIV-specific CD4+ T cells
DC Douek et al.
NATURE (2002)
HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/mL receiving combination therapy
M Hermankova et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.
SG Deeks et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques
Z Hel et al.
NATURE MEDICINE (2000)
Loss of CD4(+) T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease
JDK Wilson et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: Highly activated memory CD4+ T cells are rapidly eliminated in early SIV infection in vivo
RS Veazey et al.
JOURNAL OF VIROLOGY (2000)